Peter Fitzgerald – Chairman

Peter is Managing Director and co-founder of Randox Laboratories, a world leader in the field of protein biochip technology. Established in 1982, Randox is a multimillion pound business employing over 600 people, including 185 research scientists with distribution agreements in 130 countries.

Vivienne Williams – Director

Vivienne, a former scholar of Trinity College Dublin holds a degree in M.Sc in Physics from Trinity. Vivienne's work as a postgraduate in Microfluidics with Dmitry Kashanin and Prof. I.V. Shvets resulted in founding Cellix Ltd of which she is a co-founder and CEO. Vivienne has been working with both national and international investors and has recently raised €1.1m from European Investors in second round investments.

Igor Shvets – Director

Igor is a Professor of Physics at Trinity College Dublin, having lectured there since 1991. He is also a Fellow of Trinity College and Principal Investigator of Science Foundation Ireland (SFI). He heads an active research group of some 20 researchers. As a recognized expert and consultant in the field of nanotechnology, he is the author of more than 100 technical papers and numerous patent applications. Prof. Shvets is also co-founder of Cellix Ltd.

Dermot Kelleher – Director

Dermot is Professor of Medicine at Trinity College Dublin; Consultant Gastroenterologist in St. James’s Hospital Dublin and Director of the Institute of Molecular Medicine, Dublin. He is a Fellow of the Academy of Medical Sciences, London, and author of numerous medical papers and textbooks. Dermot is a world expert in medical research and currently heads a group of more than 50 medical researchers.

John Monahan – Director

John, an experienced CEO in managing complex high tech, biotechnology, and pharmaceutical companies. He has built and directed a number of successful teams, most recently Avigen Inc. (NASDAQ: AVGN), a company which has become a leader in its sector for the development of gene therapy products for the treatment of serious human diseases. Over 12 years as CEO, John managed serveral private and public financings and has raised over $235m as CEO in both public and private markets.

Xavier Faure – Director

Xavier, is a partner with OTC Asset Management with over 12 years experience in the private equity industry. An alumni of Ecole Polytechnique, Xavier previously invested with the LBO branch of Lazard Freres in Paris.  Xavier is also an experienced entrepreneur, having started a software company in California.